|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/18 | |
| C07K 16/40 | |||
| A61P 29/00 | |||
| A61P 37/06 |
| (11) | Patento numeris | 3095795 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16177656.2 |
| Europos patento paraiškos padavimo data | 2015-03-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-11-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-07-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201461949932 P | 2014-03-07 | US |
| (72) |
ANDRIEN, Bruce, A., Jr., US
SHERIDAN, Douglas L, US
TAMBURINI, Paul P, US
WANG, Yi, US
|
| (73) |
Alexion Pharmaceuticals, Inc.,
121 Seaport Boulevard, Boston, MA 02210,
US
|
| (54) | ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS |
| ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS |